APA (7th ed.) Citation

B, C., D, P., JH, L., & R, P. (2024). Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy. Biomedicines, 12(6), . https://doi.org/10.3390/biomedicines12061304

Chicago Style (17th ed.) Citation

B, Chern, Pinto D, Lum JH, and Parameswaran R. "Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy." Biomedicines 12, no. 6 (2024). https://doi.org/10.3390/biomedicines12061304.

MLA (9th ed.) Citation

B, Chern, et al. "Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy." Biomedicines, vol. 12, no. 6, 2024, https://doi.org/10.3390/biomedicines12061304.